Cumberland Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,000
Closed -$822K 163
2025
Q4
$822K Sell
4,000
-2,000
-33% -$376K 0.05% 143
2025
Q3
$942K Buy
+6,000
New +$927K 0.06% 134
2024
Q2
Sell
-14,537
Closed -$1.63M 176
2024
Q1
$1.63M Buy
14,537
+4,918
+51% +$531K 0.12% 101
2023
Q4
$964K Hold
9,619
0.09% 123
2023
Q3
$835K Buy
9,619
+3,250
+51% +$294K 0.08% 124
2023
Q2
$602K Buy
+6,369
New +$538K 0.06% 130
2021
Q2
Sell
-570
Closed -$35K 182
2021
Q1
$35K Buy
+570
New +$31.5K ﹤0.01% 176
2018
Q4
Sell
-9,500
Closed -$513K 170
2018
Q3
$513K Hold
9,500
0.05% 138
2018
Q2
$464K Buy
+9,500
New +$539K 0.05% 146

Other funds holding CAH

Cumberland Partners's CAH Position: Q1 2026 in Review

Cumberland Partners sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 4,000 shares — an estimated $822K sold.

Cumberland Partners first reported a position in CAH in Q2 2018 and held it in 9 quarters. The position peaked at $1.63M in Q1 2024. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Cumberland Partners reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Cumberland Partners sold 4,000 Cardinal Health shares in Q1 2026, an estimated $822K.
  • Cumberland Partners first reported a position in Cardinal Health in Q2 2018 and held it in 9 quarters.
  • Cumberland Partners's Cardinal Health position peaked at $1.63M in Q1 2024.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Cumberland Partners's 13F filing for Q1 2026, filed 14 May 2026.